Introduction Cytologic detection of peritoneal gastric cancer cells by Papanicolaou staining offers important prognostic information but has low sensitivity. We evaluated a novel detection technique using Newcastle disease virus expressing the enhanced green fluorescent protein (NDV-GFP) gene.
Introduction
Gastric cancer is the fourth most common cancer globally 1 and is particularly prevalent in Asian countries. Within the USA, over 21,000 new cases were estimated to occur in 2008 alone. 2 Staging of gastric cancer is currently done by endoscopy with biopsy and various imaging modalities, including endoscopic ultrasound (EUS) and computed tomography (CT). 3, 4 Diagnostic laparoscopy has emerged as a better means of excluding metastases in the peritoneum while also enabling the procurement of lavage washings for cytologic examination. Positive cytologic washings, as determined by the Papanicolaou (Pap) stain, confer the same poor prognosis as overt metastases. [5] [6] [7] Cytology, however, is not always positive in cases of obvious metastatic disease and has a low sensitivity of 54-59%. 8, 9 A more sensitive means of diagnosing free peritoneal cancer cells would allow for identification of those patients who may benefit from adjuvant therapy.
Newcastle disease virus (NDV) is a member of the Paramyxoviridae family, is replication competent, and contains a nonsegmented, negative-stranded RNA genome. 10 It is known to be pathogenic in birds but does not cause toxicity in humans. Several trials have noted clinical benefit after administration of naturally occurring NDV in metastatic or malignant tumors refractory to standard care, such as melanoma and various solid tumors. 11, 12 The recent establishment of the reverse-genetics system has allowed for genetic manipulation of the NDV virus, thereby enhancing its oncolytic effect, as well as inserting a reporter gene, such as the enhanced green fluorescent protein (eGFP). 13, 14 The NDV containing the eGFP marker gene, NDV-GFP, may offer a novel diagnostic modality in evaluation of peritoneal lavage fluid from patients with gastric cancer.
This study set out to determine whether the recombinant NDV-GFP virus, which has been designed to specifically target and infect gastric cancer cells, could be used diagnostically. Virally mediated detection of free peritoneal cancer cells from patients undergoing staging diagnostic laparoscopy for gastric cancer was then investigated as a means of detection and compared with cytologic examination by the Pap stain.
Materials and Methods

Cell Culture
The MKN-1 cell line, an adenosquamous cell carcinoma, was kindly provided by Dr. T. Suzuki (Fukushima Medical College, Japan) and was cultured in Roswell Park Memorial Institute (RPMI) medium supplemented with 10% fetal bovine serum (FBS), 1% penicillin, and 1% streptomycin.
Virus
The attenuated NDV Hitchner B1 strain (NDV-B1) was modified with the reverse-genetics system. 15, 16 To generate NDV expressing GFP, a GFP DNA fragment flanked by the appropriate NDV-specific RNA transcriptional signals was inserted into the XbaI site created between the P and M genes of pT7NDV of F3aa. Viruses were rescued from complementary cDNA using methods described previously and sequenced by reverse transcription-polymerase chain reaction for insert fidelity.
Rat Hepatocyte Study
All animal studies were done in accordance with Memorial Sloan-Kettering Cancer Center's (MSKCC's) Institute of Animal Care and Use Committee under an approved protocol. Adult male Sprague Dawley rats were anesthetized using 2% inhalational isoflurane mixed with 3 l of oxygen. A midline laparotomy was performed and the liver isolated. The portal vein was cannulated and perfused with warm liver perfusion medium followed by Liver Digest Medium (Gibco, Grand Island, NY, USA). Rat hepatocytes were isolated and cultured according to the manufacturer's protocol on six-well plates coated with 1% rat tail collagen and incubated at 37°C. Four hours after plating the hepatocytes, MKN-1 cells were added at a ratio of one cancer cell against a background of one million rat hepatocytes. Twenty-four hours later, the plates were infected with NDV-GFP at a dose of 5×10 6 PFU and evaluated for GFP expression.
Patient Study
All patient samples were collected under an InstitutionalReview-Board-approved tissue collection protocol with patient consent. Thirty patients underwent diagnostic laparoscopy at MSKCC for biopsy-proven gastric adenocarcinoma. Normal saline was instilled into the peritoneal cavity, and lavage samples were collected from the right upper quadrant, left upper quadrant, and pelvis. Duplicate samples from each site were obtained from every patient; half were sent to the pathology department for evaluation, and the other half were transported to the laboratory on ice. The lavage fluid was combined and placed in 50-ml conicals and centrifuged at 800 rpm for 5 min to obtain a cell pellet. This pellet was then washed once with phosphate-buffered saline (PBS), resuspended in 1-ml RPMI media containing 10% FBS and 1% penicillin and streptomycin, plated in four-well chamber slides, and incubated at 37°C.
NDV-GFP Dose Optimization
A sample of grossly malignant ascites was obtained from the operating room and processed in the above-described fashion. Wells were incubated with single doses of NDV-GFP ranging from 5×10 3 to 5×10 7 PFU. Fluorescence microscopy was performed after 12 h of incubation to evaluate for number of green fluorescent cells visualized per high-powered field.
Viral Infection and Costaining for CEA
After a minimum of 6 h and up to 24 h of incubation, 500 μl of media was aspirated carefully from each well of the chamber slide. NDV-GFP 5×10 6 PFU was added to the remaining media and left at room temperature. Five hundred microliters of media was added back after 30 min, and the chamber slide returned to 37°C. Samples were also counterstained with phycoerythrin-anti-carcinoembryonic antigen (CEA; BD Pharmingen, Franklin Lakes, NJ, USA).
Fluorescence Microscopy
All samples were evaluated with an inverted microscope (Nikon Eclipse TE300, Nikon, Tokyo, Japan) using phase contrast and fluorescence microscopy. A GFP emission filter was used to detect green fluorescence and a TRIT-C filter for the red fluorescent CEA antibody. Images were obtained using NIS software.
Immunofluorescent Staining
Samples were washed with PBS and fixed with 4% paraformaldehyde for 20 min. The cells were lysed with 1% Triton-X and incubated in rabbit anti-NDV antibody for 2 h. Incubation for 1 h with Alex-fluor 532 secondary antibody followed. The slide was then mounted with mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) and evaluated with fluorescence microscopy.
Results
Detection of MKN-1 Cells Against Benign Hepatocytes
To confirm that NDV-GFP infects cancer cells but not cells of noncancerous origin, one MKN-1 cell was plated on a background of one million benign rat hepatocytes and infected with NDV-GFP. At a dose of 5×10 6 PFU, NDV-GFP was able to detect one cancer cell against a background of one million benign rat hepatocytes (Fig. 1) . GFP expression was seen as early as 6 h and continued for over 24 h. This demonstrated that NDV was both sensitive and specific for gastric cancer cell detection.
Dose Optimization
To optimize the dose of NDV for maximum detection benefit, grossly positive ascites were infected with different doses of NDV, and the numbers of cancer cells that were detectable by GFP expression among the different groups were compared. NDV-GFP produced detectable GFP expression with as low a dose as 5×10 3 PFU after 12 h of incubation. The number of GFP-positive cells increased with increasing doses of virus from one GFP-positive cell per high-powered field at a dose of 5×10 3 PFU to nine GFP-positive cells per high-powered field with a dose of 5×10 7 PFU (Fig. 2) . A dose of 5×10 6 PFU, which produced five GFP-positive cells per high-powered field, was chosen as the dose of NDV-GFP with which to proceed, since this dose was the most practical and provided the best balance of viral dose and number of green-fluorescent-positive cells. Also noted were that noncancerous cells, such as erythrocytes and fibroblasts, determined by phenotypic appearance, were also non-GFP expressing.
Evaluation of Peritoneal Washing Samples
We proceeded to evaluate the detection of gastric cancer cells in peritoneal washings using the NDV-GFP virus. GFP-positive cells were found in both cytology-negative and cytology-positive samples (Fig. 3a, b) . Other cell types, such as red blood cells and dendritic cells, were GFP negative. GFP-positive cells were detected in 29 of 30 (97%) samples. Cytology, in comparison, was positive in three of 30 (10%). Of the six patients found to have metastatic disease at laparoscopy, GFP-positive cells were found in all washing samples. Cytology, however, was positive in only half of these cases. Overall, NDV-GFP offered a greater sensitivity in detecting gross disease, p< 0.01 (Table 1) .
There was no correlation between patient gender or tumor location and the detection of free peritoneal cancer Figure 1 Representative phase contrast and GFP images of MKN-1 gastric adenocarcinoma cells against benign rat hepatocytes after infection with NDV-GFP for 24 h. NDV-GFP can detect one MKN-1 cancer cell against a background of one million benign hepatocytes. cells, either by cytology or by NDV-GFP (Table 1) . Based on EUS, CT, and diagnostic laparoscopy findings, 13 patients were considered stages 1 or 2, while 17 patients were considered stages 3 or 4. NDV-GFP was positive in 100% of stage 3-4 patients, while cytology was positive in only 18% (Table 1) . Additionally, 22 patients were determined to have T3 disease or tumors that penetrated the serosa. Of these, two of 22 (9%) were cytology positive, while 21 of 22 (95%) were found to be NDV-GFP positive. Fifteen patients were determined to have N1 or N2 disease. Of these, two of 15 (13%) were cytology positive, while all 15 (100%) of patients were NDV-GFP positive (Table 1 ). GE gastroesophageal, EUS endoscopic ultrasound, CT computed tomography After diagnostic laparoscopy, 23 patients ultimately underwent resection. Of these, 22 of 23 (96%) had GFP-positive cells as detected by NDV-GFP. None of the patients were cytology positive. Of the 17 patients found to have vascular invasion on pathology, all were NDV-GFP positive (Table 2 ). Similarly, all nine patients found to have perineural invasion and all seven patients found to have positive margins on pathologic examination were also found to be NDV-GFP positive and cytology negative.
Counterstaining for CEA
To confirm that these GFP-positive cells were indeed cancer cells, the samples were costained with anti-CEA antibody. Using fluorescence microscopy, the GFP-positive cells were shown to costain for CEA (Fig. 3c) , further confirming their cancerous origin.
Immunofluorescent Staining
To confirm that the GFP-positive cells were fluorescent due to NDV-GFP infection, human samples were processed in the manner described above, evaluated with fluorescent microscopy for GFP and CEA expression, and then fixed with 4% paraformaldehyde. These samples were then stained with anti-NDV antibody, anti-CEA antibody, and appropriate secondary antibodies. As can be seen in Fig. 4 , cells that were stained for NDV antigens also costained for CEA, confirming that only cancer cells were infected with NDV.
Discussion
Gastric cancer is the fourth most common cancer globally. 2 While metastatic disease still carries a median survival of less than a year with chemotherapy, 17 patients who can be preoperatively identified as having high risk for advanced disease would benefit from a treatment paradigm that differs from the treatment plan for patients with earlystage disease. Diagnostic laparoscopy has proven to be both a useful tool in diagnosing subradiologic metastatic disease, as well as providing a means to evaluate peritoneal lavage cytology. 9 Multiple studies have demonstrated that positive peritoneal cytology, as determined by the Pap stain, confers the same prognosis as does gross metastatic disease. 5, 7 NDV has been studied for its natural tumor specificity and oncolytic properties since the late 1950s. 18 The establishment of the reverse-genetics system for the virus has allowed for modifications enhancing cancer specificity and incorporation of marker genes, such as GFP, thereby allowing for tracking of viral replication. 14 The current study set out to determine if virally mediated detection of free peritoneal cancer cells in patients undergoing diagnostic laparoscopy for biopsy-proven gastric adenocarcinoma would offer a more sensitive method of detection, as compared to conventional Pap staining.
The results of this study demonstrated that NDV-GFP was able to specifically detect cancer cells and express GFP upon a background of benign rat hepatocytes, as well as in human peritoneal lavage samples. Noncancerous cells, such red blood cells and fibroblasts, were non-GFP expressing. Counterstaining for CEA in the human lavage samples confirmed the cancerous origin of the GFP-positive cells. NDV-GFP-mediated detection offers significantly more sensitivity compared with conventional cytology. Even in patients who were found to have gross peritoneal disease during laparoscopy, NDV-GFP detected positive cells in all cases, while Pap staining was positive in only 50% of those patients. NDV-GFP was also able to identify free peritoneal gastric cancer cells in the majority of those patients found to have more advanced disease, such as stage 3-4 disease, T3, and N1 or N2 tumors. Positive gastric cancer cells were also identified in the peritoneal washings of all patients found to have vascular invasion, perineural invasion, and positive margins within the resected specimen, while Pap staining was negative. These results suggest that NDV-GFP may better identify those patients who have risk factors for recurrence. Future clinical follow-up is needed to determine the prognostic significance of finding free peritoneal gastric cancer cells by this more sensitive, virally mediated method and how the identification of these cells may affect treatment.
Conclusion
NDV-GFP-mediated detection of gastric cancer cells offers a rapid and more sensitive method of identifying free peritoneal gastric cancer cells in peritoneal lavage fluid compared with conventional Pap staining. While positive peritoneal cytology by Pap staining confers the same poor prognosis as does metastatic disease, long-term clinical follow-up is needed to ascertain the prognostic impact of positive NDV-GFP status.
Discussant
Dr. Sarah Thayer (Massachusetts General Hospital, Boston, MA): First, may I congratulate you on a job well done for your work, which was very well presented.
I think that your study has nicely shown another enhanced detection technique for these free peritoneal cells using the Newcastle disease virus. I think what you have shown is an extraordinarily sensitive technique.
But the question still remains, how specific is this technique? And can the specificity be used to ascertain those patients who are at high risk of recurrence or at advanced stage of disease?
I think the difficulty in making any conclusions actually stems from your data-that nearly 100 percent of your patient population was GFP-positive.
So it comes as no surprise, then, that positive GFP cells were found in advanced-stage disease. It's also true, if you think about it, that 100 percent of your patients with very early-stage disease and good prognostic factors were also GFP-positive. So this raises the specter of specificity with this particular enhanced detection technique.
So my questions are three, and they really focus around the specificity of this technique. The first: Your control experiment done on the patient revealed that your virus was sensitive; however, the contaminating cells in cytology are mesothelial and inflammatory cells. Did you perform any control to make sure your Newcastle disease virus did not stain mesothelial or inflammatory cells?
Closing Discussant Dr. Joyce Wong: Interestingly, if you were to look at the washing specimens, sometimes you see macrophages or dendritic cells exhibit very low fluorescence. But with fluorescence microscopy, you can actually gait the level that you determine GFP to be positive. So when you raise the threshold, you will gait out all sort of cells that exhibit low-level fluorescence, such as dendritic cells or macrophages, which you can confirm phenotypically.
The GFP or fluorescence that the dendritic cells show could be autofluorescence. The GFP expression is much lower than what you see in the cancer cells, which you can also detect morphologically. Discussant Dr. Sarah Thayer: My second question is: Going back looking at your patient samples again, you showed very nicely that the CEA-positive cells were, in fact, green fluorescent protein-positive. However, also in the same field, we saw a lot of GFP-positive cells that were not CEA-positive; there were also a lot of CEA-positive cells that didn't co-localize with GFP. So I wonder whether or not you went ahead and looked at those significant GFPpositive cells and confirmed that in fact they were cancer, and if so, what methodology you used to confirm that they were cancer.
Closing Discussant Dr. Joyce Wong: I think what we need to do is actually go back and look at markers other than CEA. There is also an interesting time correlation between GFP and CEA expression. With viral infection, as the virus gets taken in by the cell and starts to replicate, the cancer cells actually lose CEA expression. So there is a very definite window of time between administering our virus and evaluating with microscopy where you can see the co-localization of CEA and GFP. We also used a dose of virus that was low enough that we did not infect every cell at once.
So we believe that the CEA positive cells are just not infected with virus yet. I think that in those particular panels, the GFP positive cells could have been either at one point CEA positive, or they are cancer cells, or we believe them to be cancer cells, that would be positive by a marker other than CEA. We are currently investigating other markers. Discussant Dr. Sarah Thayer: My final question actually has to do with this virus. It's an incredibly interesting virus when you go back to its history. I'm surprised that we can have access to it and use it.
The reason why, as you said, is that clearly it's an avian virus. But it has the capability of infecting human cells, and there are spontaneous mutants that affect the neurons and respiratory epithelia. And, actually, if you look at the history of this virus, it was studied by the U.S. Defense Department as an agent of biological warfare.
So now I ask you how you modify this virus so that it appears to have a sensitivity to (now) gastric cancer epithelia, and whether you also then plan to use it for its oncolytic properties, and not as a marker?
Closing Discussant Dr. Joyce Wong: There actually have been a number of studies in our lab that have used it against melanoma, mesothelioma, and gastric cancer. The NDV virus specifically targets cancer cells because of the defective interferon pathways within tumor cells that are not present in normal cells. So normal cells are not able to replicate NDV, and NDV does not infect them.
We have been able to insert various proteins and various genes within the NDV genome that makes it more oncolytic, so the idea would be to eventually use it as a cancer therapeutic agent and not just a diagnostic tool. We use the GFP marker gene in this situation purely for diagnostic reasons.
Closing Closing Discussant Dr. Joyce Wong: In the washings, we basically used as high a dose as we could use to try and detect as many cancer cells as possible. When we receive washings, we don't know the number of cancer cells that would be contained in that washing. Not all of the cells that you see will be malignant cells. There will be blood cells and other types of cells.
When we talk about viral infections, typically we talk about multiplicity of infection, or the MOI, which is the number of viral particles relative to cancer cells. When we screened gastric cancer cell lines, we found that there was a great deal of uptake with an MOI of one. So, for example, in this situation we really are talking about MOIs of 100 or 1,000. So the efficiency should be quite high. Discussant Dr. Michael Sarr: Then why weren't more cells stained? The number of cancer cells were few?
Closing Discussant Dr. Joyce Wong: Right. Number one, the number of cancer cells were so few. Secondly, the timeline to evaluating washings is after about 12 hours of incubation. If you were to allow the virus time to replicate more, say at 24 hours or 48 hours, you would, probably, see higher degrees of GFP-expressing cells. But then the optimal balance between viral infection, replication, and lysis would have to be determined. Discussant Dr. Michael G. Sarr: You saw so many positive cells with stage one and stage two. How can you use this then, clinically.
Closing Discussant Dr. Joyce Wong: I think we need longer-term followup. Basically, we may be, perhaps, understaging patients. If we can detect peritoneal cancer cells in the lavage specimens, perhaps these patients are not, in fact, stage 1 and stage 2 patients. I think, ultimately, we need to follow these patients out to see if there is disease recurrence or survival.
